AIT Bioscience has partnered with Dr. Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, to serve as a senior research advisor. Dr. Bowsher has more than 35 years of experience in biotherapeutic drug research in both the pharmaceutical and CRO industries. He will advise AIT on technical, regulatory, and business development matters related to ligand binding methods.
“I am excited about my advisory role at AIT Bioscience, because I believe this organization is both highly innovative and customer-focused,” said Dr. Bowsher. The AIT Bioscience team is dedicated to providing both innovative and quality services as demonstrated by their cutting-edge use of electronic lab notebooks. I’m looking forward to helping them grow and expand their services for bioanalysis of large molecules, in order to help clients achieve expedited, quality data.”
“Dr. Bowsher is a pioneer in our industry and we are honored to have him as an advisor to our management team. His demonstrated leadership in ligand binding assays opens our services to a broader pipeline of molecules, allowing more clinical and non-clinical studies to benefit from our fully integrated electronic laboratory documentation system,” said AIT Bioscience president Dr. Ron Shoup.